CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
+14.72%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(-13%)
Cap. Flow
-$81.1M
Cap. Flow
% of AUM
-24.61%
Top 10 Holdings %
Top 10 Hldgs %
86.21%
Holding
30
New
7
Increased
6
Reduced
8
Closed
5
Top Buys
| 1 |
SLRN
ACELYRIN
SLRN
|
$55.7M |
| 2 |
Keros Therapeutics
KROS
|
$5.67M |
| 3 |
Disc Medicine
IRON
|
$5.56M |
| 4 |
Direxion Daily S&P Biotech Bear 3X Shares
LABD
|
$4.67M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$3.92M |
Top Sells
Sector Composition
| 1 | Healthcare | 98.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pliant Therapeutics
PLRX
$101M
| $56.5M | 17.14% | 3,117,017 +115,182 | +4% | +$2.09M |
|
|
SLRN
2
DELISTED
ACELYRIN
SLRN
| $55.7M | 16.89% | +2,663,806 | New | +$55.7M |
|
|
VECT
3
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $46.9M | 14.24% | 2,782,756 -2,472,728 | -47% | -$41.7M |
|
4
Cullinan Oncology
CGEM
$445M
| $36.7M | 11.15% | 3,414,189 +64,729 | +2% | +$696K |
|
5
Repare Therapeutics
RPTX
$71.7M
| $31.7M | 9.63% | 2,998,734 +795 | +0% | +$8.41K |
|
|
6
Keros Therapeutics
KROS
$618M
| $16.2M | 4.9% | 402,118 +141,059 | +54% | +$5.67M |
|
|
IMA
7
ImageneBio, Inc. Common Stock
IMA
$150M
| $13.9M | 4.22% | 2,122,040 +461,168 | +28% | +$3.03M |
|
8
Compass Therapeutics
CMPX
$483M
| $9M | 2.73% | 2,829,712 | – | – |
|
9
Larimar Therapeutics
LRMR
$310M
| $8.72M | 2.65% | 3,414,468 +668,203 | +24% | +$1.71M |
|
|
TSVT
10
DELISTED
2seventy bio
TSVT
| $8.62M | 2.62% | 852,007 -2,993 | -0.4% | -$30.3K |
|
|
INZY
11
DELISTED
Inozyme Pharma
INZY
| $6.66M | 2.02% | 1,195,027 -147,164 | -11% | -$820K |
|
|
OMGA
12
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $5.91M | 1.79% | 1,055,882 | – | – |
|
|
13
Disc Medicine
IRON
$2.07B
| $5.56M | 1.69% | +125,139 | New | +$5.56M |
|
|
14
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$68.5M
| $4.67M | 1.42% | +325,000 | New | +$4.67M |
|
|
ORTX
15
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.94M | 1.19% | 755,738 -30,000 | -4% | -$156K |
|
|
16
Ultragenyx Pharmaceutical
RARE
$2.89B
| $3.92M | 1.19% | +85,000 | New | +$3.92M |
|
17
Black Diamond Therapeutics
BDTX
$157M
| $3.79M | 1.15% | +750,000 | New | +$3.79M |
|
18
Rallybio
RLYB
$22.4M
| $3.07M | 0.93% | 542,774 -217,769 | -29% | -$1.23M |
|
19
Ovid Therapeutics
OVID
$91M
| $2.84M | 0.86% | 864,822 | – | – |
|
|
SYRS
20
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.42M | 0.73% | 767,445 | – | – |
|
21
Precision BioSciences
DTIL
$57.8M
| $843K | 0.26% | 1,603,557 -1,866,263 | -54% | -$982K |
|
|
HOOK
22
DELISTED
HOOKIPA Pharma
HOOK
| $694K | 0.21% | +788,740 | New | +$694K |
|
|
LENZ
23
LENZ Therapeutics
LENZ
$1.1B
| $600K | 0.18% | +230,938 | New | +$600K |
|
24
Corvus Pharmaceuticals
CRVS
$428M
| $458K | 0.14% | 200,000 -2,139,402 | -91% | -$4.9M |
|
|
FRLN
25
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $55.9K | 0.02% | 21,666 -4,707,753 | -100% | -$12.1M |
|